Curaleaf Holdings (CURLF) Cash from Operations Growth (1y) (2020 - 2024)
Curaleaf Holdings (CURLF) Cash from Operations Growth (1y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 251.12% |
| Sep 30, 2024 | -9.50% |
| Jun 30, 2024 | -454.52% |
| Mar 31, 2024 | 454.41% |
| Dec 31, 2023 | -59.00% |
| Sep 30, 2023 | 6.45% |
| Jun 30, 2023 | -11,641.34% |
| Mar 31, 2023 | 13,644.84% |
| Dec 31, 2022 | 208.38% |
| Sep 30, 2022 | -14.90% |
| Jun 30, 2022 | 8.23% |
| Mar 31, 2022 | 1,060.17% |
| Dec 31, 2021 | -260.88% |
| Sep 30, 2021 | 180,448.47% |
| Jun 30, 2021 | -411.93% |
| Mar 31, 2021 | -265.93% |
| Dec 31, 2020 | 205.85% |
| Sep 30, 2020 | 2,055.50% |